See more : Yihua Healthcare Co., Ltd. (000150.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of TILT Holdings Inc. (TLLTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TILT Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Bilfinger SE (GBF.SW) Income Statement Analysis – Financial Results
- Vallourec S.A. (VLOUF) Income Statement Analysis – Financial Results
- Accel Solutions Group Ltd (ACCL.TA) Income Statement Analysis – Financial Results
- AVEVA Group plc (AVEVF) Income Statement Analysis – Financial Results
- Blue Foundry Bancorp (BLFY) Income Statement Analysis – Financial Results
TILT Holdings Inc. (TLLTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.tiltholdings.com
About TILT Holdings Inc.
TILT Holdings Inc. operates in the cannabis industry in the United States, Canada, Israel, Mexico, South America, and the European Union. It operates through Cannabis, Accessories, and Other segments. The company engages in the production, cultivation, extraction, and sale of cannabis products; manufacture and distribution of electronic and non-nicotine devices and systems; and focuses on greenhouse cultivation and CO2 extraction. It also processes and provides medical cannabis products, including flower, infused products, concentrates, topicals, tinctures, vape cartridges, and syringes. The company is headquartered in Phoenix, Arizona.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 165.96M | 174.19M | 202.71M | 158.41M | 152.94M | 5.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 154.34K | 1.55M | 1.99M | 1.74M | 0.00 | 0.00 |
Cost of Revenue | 147.18M | 136.02M | 144.50M | 99.45M | 97.80M | 3.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 31.55K | 271.83K | 280.14K | 188.04K | 0.00 | 0.00 |
Gross Profit | 18.77M | 38.17M | 58.21M | 58.96M | 55.14M | 2.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 122.79K | 1.27M | 1.71M | 1.55M | 0.00 | 0.00 |
Gross Profit Ratio | 11.31% | 21.91% | 28.71% | 37.22% | 36.05% | 43.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 79.56% | 82.41% | 85.90% | 89.19% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 106.00K | 62.12K | 98.23K | 16.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.97K | 334.44K | 552.49K | 505.95K | 0.00 | 0.00 |
General & Administrative | 19.46M | 46.09M | 37.52M | 40.21M | 129.89M | 51.89M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 448.27K | 816.31K | 1.20M | 1.39M | 0.00 | 0.00 |
Selling & Marketing | 1.16M | 2.45M | 2.16M | 611.00K | 2.20M | 718.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.79K | 416.69K | 747.45K | 1.50M | 0.00 | 0.00 |
SG&A | 20.62M | 48.54M | 39.68M | 40.82M | 132.09M | 51.89M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 493.06K | 1.23M | 1.95M | 2.89M | 59.01K | 4.54K |
Other Expenses | 41.31M | 18.35M | 18.46M | 18.52M | 24.72M | 648.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 980.42K | -40.32K | -140.33K | -187.45K | 0.00 | 0.00 |
Operating Expenses | 61.93M | 66.89M | 58.25M | 59.34M | 156.81M | 52.54M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 505.03K | 1.53M | 2.36M | 3.21M | 59.01K | 4.54K |
Cost & Expenses | 209.11M | 202.91M | 202.75M | 158.79M | 254.61M | 55.75M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 536.58K | 1.80M | 2.64M | 3.40M | 59.01K | 4.54K |
Interest Income | 0.00 | 215.00K | 592.00K | 3.84M | 3.28M | 44.12K | 33.41 | 190.54 | 636.45 | 1.67K | 2.70K | 0.00 | -0.78 | -0.72 | -0.33 | 0.00 | 0.00 | |
Interest Expense | 21.00M | 14.24M | 10.99M | 10.34M | 13.81M | 1.00B | 33.41 | 190.54 | 636.45 | 1.67K | 2.70K | 0.00 | 135.56K | 58.22K | 210.33K | 0.00 | 0.00 | |
Depreciation & Amortization | 21.95M | 22.00M | 21.28M | 19.49M | 23.50M | 615.78K | 15.93M | -363.22 | 1.27K | 3.35K | -49.95K | 0.00 | 980.42K | 17.35K | 30.09K | 43.34K | 8.95K | 189.07 |
EBITDA | -25.06M | -64.65M | -17.04M | -29.62M | -90.84M | -521.40M | -46.28K | -43.94K | -55.82K | -84.04K | -153.15K | -141.59K | 598.18K | -235.74K | -624.09K | -1.61M | -59.01K | -4.54K |
EBITDA Ratio | -15.10% | -2.29% | 11.63% | 16.49% | -45.55% | 8,000.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -247.65% | -12.05% | -31.42% | -92.80% | 0.00% | 0.00% |
Operating Income | -43.15M | -28.72M | 272.00K | 4.50M | -101.67M | 451.92M | -46.28K | -43.42K | -55.19K | -82.36K | -152.72K | -141.59K | -382.24K | -303.30K | -654.84K | -1.66M | -59.01K | -4.54K |
Operating Income Ratio | -26.00% | -16.49% | 0.13% | 2.84% | -66.48% | 7,988.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -247.65% | -19.63% | -32.97% | -95.32% | 0.00% | 0.00% |
Total Other Income/Expenses | -24.00M | -13.60M | -8.80M | -22.55M | -16.13M | -493.78M | 16.34M | -553.76 | 865.32 | 2.06K | 0.00 | 0.00 | 968.99K | -132.33K | -60.55K | -442.87K | 0.00 | 0.00 |
Income Before Tax | -67.16M | -104.46M | -50.15M | -57.15M | -140.03M | -552.07M | -46.25K | -43.97K | -55.19K | -82.36K | -152.72K | -141.59K | 598.18K | -303.30K | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -40.47% | -59.97% | -24.74% | -36.08% | -91.56% | -9,758.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 387.56% | -19.63% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 3.34M | 3.01M | -5.03M | -5.04M | -6.66M | 47.74K | -66.83 | 363.22 | -1.27K | -3.35K | 49.95K | 0.00 | -980.42K | 185.09K | 58.22K | 210.33K | -8.95K | -189.07 |
Net Income | -62.38M | -107.46M | -45.12M | -52.11M | -133.37M | -552.12M | -46.25K | -43.97K | -55.19K | -82.36K | -152.72K | -141.59K | 586.75K | -438.87K | -713.06K | -1.87M | -50.06K | -4.35K |
Net Income Ratio | -37.59% | -61.69% | -22.26% | -32.89% | -87.21% | -9,759.70% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 380.16% | -28.40% | -35.90% | -107.42% | 0.00% | 0.00% |
EPS | -0.16 | -0.29 | -0.12 | -0.14 | -0.37 | -18.36 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | 0.26 | -0.28 | -0.51 | -1.62 | -1.13 | -0.06 |
EPS Diluted | -0.16 | -0.29 | -0.12 | -0.14 | -0.37 | -18.36 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | 0.26 | -0.28 | -0.51 | -1.62 | -1.13 | -0.06 |
Weighted Avg Shares Out | 379.58M | 375.50M | 370.00M | 364.56M | 355.84M | 30.07M | 7.81M | 7.81M | 7.81M | 7.81M | 7.81M | 7.78M | 2.26M | 1.54M | 1.40M | 1.15M | 44.49K | 74.67K |
Weighted Avg Shares Out (Dil) | 379.58M | 375.50M | 370.00M | 364.56M | 355.84M | 30.07M | 7.81M | 7.81M | 7.81M | 7.81M | 7.81M | 7.78M | 2.26M | 1.54M | 1.40M | 1.15M | 44.49K | 74.67K |
Jupiter's Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?
TILT Holdings Inc. (TLLTF) Q3 2024 Earnings Call Transcript
TILT Holdings Reports Third Quarter 2024 Results and Announces Strategic Review of its Plant-Touching Business
TILT Sets Third Quarter 2024 Conference Call for November 14 at 5:00 p.m. ET
TILT Holdings Announces the Departure of its Chief Revenue Officer
TILT Holdings Announces Board Changes
Village Farms And TILT Holdings: A Tale Of Two Cannabis Companies Facing Diverging Fortunes
TILT Holdings Reports Second Quarter 2024 Results
TILT Holdings Launches Flower by Edie Parker in Pennsylvania
TILT Sets Second Quarter 2024 Conference Call for August 9 at 8:30 a.m. ET
Source: https://incomestatements.info
Category: Stock Reports